Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons

被引:28
|
作者
Hinman, Melissa N. [1 ]
Sharma, Alok [1 ]
Luo, Guangbin [1 ,3 ]
Lou, Hua [1 ,2 ,3 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA
基金
美国国家卫生研究院;
关键词
GTPASE-ACTIVATING PROTEIN; PRE-MESSENGER-RNA; EMBRYONIC STEM-CELLS; GAP-RELATED DOMAIN; GENE-PRODUCT; POLYPYRIMIDINE TRACT; MOUSE MODEL; NF1; GENE; LEARNING-DEFICITS; DEVELOPMENTAL REGULATION;
D O I
10.1128/MCB.00019-14
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis type I (Nf1) is a GTPase-activating protein (GAP) that inactivates the oncoprotein Ras and plays important roles in nervous system development and learning. Alternative exon 23a falls within the Nf1 GAP domain coding sequence and is tightly regulated in favor of skipping in neurons; however, its biological function is not fully understood. Here we generated mouse embryonic stem (ES) cells with a constitutive endogenous Nf1 exon 23a inclusion, termed Nf1 23aIN/23aIN cells, by mutating the splicing signals surrounding the exon to better match consensus sequences. We also made Nf1 23a Delta/23a Delta cells lacking the exon. Active Ras levels are high in wild-type (WT) and Nf1 23aIN/23aIN ES cells, where the Nf1 exon 23a inclusion level is high, and low in Nf1 23a Delta/23a Delta cells. Upon neuronal differentiation, active Ras levels are high in Nf1 23aIN/23aIN cells, where the exon inclusion level remains high, but Ras activation is low in the other two genotypes, where the exon is skipped. Signaling downstream of Ras is significantly elevated in Nf1 23aIN/23aIN neurons. These results suggest that exon 23a suppresses the Ras-GAP activity of Nf1. Therefore, regulation of Nf1 exon 23a inclusion serves as a mechanism for providing appropriate levels of Ras signaling and may be important in modulating Ras-related neuronal functions.
引用
收藏
页码:2188 / 2197
页数:10
相关论文
共 50 条
  • [31] Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders
    Jessica A. Kaczorowski
    Taylor F. Smith
    Amanda M. Shrewsbury
    Leah R. Thomas
    Valerie S. Knopik
    Maria T. Acosta
    Behavior Genetics, 2020, 50 : 191 - 202
  • [32] Key features of choroidal abnormalities in neurofibromatosis type 1, a commentary on "Histologic correlates of "choroidal abnormalities" in neurofibromatosis type 1 (NF1)"
    Lucchino, Luca
    Mallone, Fabiana
    Gharbiya, Magda
    Alisi, Ludovico
    ACTA NEUROPATHOLOGICA, 2024, 148 (01)
  • [33] Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2
    Kaufmann, D
    Leistner, W
    Kruse, P
    Kenner, O
    Hoffmeyer, S
    Hein, C
    Vogel, W
    Messiaen, L
    Bartelt, B
    CANCER RESEARCH, 2002, 62 (05) : 1503 - 1509
  • [34] Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
    R. Koster
    R. D. Brandão
    D. Tserpelis
    C. E. P. van Roozendaal
    C. N. van Oosterhoud
    K. B. M. Claes
    A. D. C. Paulussen
    M. Sinnema
    M. Vreeburg
    V. van der Schoot
    C. T. R. M. Stumpel
    M. P. G. Broen
    L. Spruijt
    M. C. J. Jongmans
    S. A. J. Lesnik Oberstein
    A. S. Plomp
    M. Misra-Isrie
    F. A. Duijkers
    M. J. Louwers
    R. Szklarczyk
    K. W. J. Derks
    H. G. Brunner
    A. van den Wijngaard
    M. van Geel
    M. J. Blok
    npj Genomic Medicine, 6
  • [35] Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
    Koster, R.
    Brandao, R. D.
    Tserpelis, D.
    van Roozendaal, C. E. P.
    van Oosterhoud, C. N.
    Claes, K. B. M.
    Paulussen, A. D. C.
    Sinnema, M.
    Vreeburg, M.
    van der Schoot, V
    Stumpel, C. T. R. M.
    Broen, M. P. G.
    Spruijt, L.
    Jongmans, M. C. J.
    Oberstein, S. A. J. Lesnik
    Plomp, A. S.
    Misra-Isrie, M.
    Duijkers, F. A.
    Louwers, M. J.
    Szklarczyk, R.
    Derks, K. W. J.
    Brunner, H. G.
    van den Wijngaard, A.
    van Geel, M.
    Blok, M. J.
    NPJ GENOMIC MEDICINE, 2021, 6 (01)
  • [36] Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1
    Jang, Mi-Ae
    Kim, Young-Eun
    Kim, Sun Kyung
    Lee, Myoung-Keun
    Kim, Jong-Won
    Ki, Chang-Seok
    JOURNAL OF HUMAN GENETICS, 2016, 61 (08) : 705 - 709
  • [37] Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1
    Mi-Ae Jang
    Young-Eun Kim
    Sun Kyung Kim
    Myoung-Keun Lee
    Jong-Won Kim
    Chang-Seok Ki
    Journal of Human Genetics, 2016, 61 : 705 - 709
  • [38] Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism
    Goodson, Michael L.
    Knotts, Trina A.
    Campbell, Elsie L.
    Snyder, Chelsea A.
    Young, Briana M.
    Privalsky, Martin L.
    PLOS ONE, 2020, 15 (10):
  • [39] TISSUE-SPECIFIC ALTERNATIVE SPLICING OF NEUROFIBROMATOSIS-1 (NF1) MESSENGER-RNA
    DANGLOT, G
    TEINTURIER, C
    DUVERGER, A
    BERNHEIM, A
    BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (8-9) : 365 - 372
  • [40] Alternative splicing of the FMR1 gene in human fetal brain neurons
    Huang, T
    Li, LY
    Shen, Y
    Qin, XB
    Pang, ZL
    Wu, GY
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 64 (02): : 252 - 255